Overview
The 26th Annual International Congress on the Future of Breast Cancer® West will provide clinicians with cutting-edge updates on recent advances in the treatment of breast cancer, from preclinical breakthroughs to changes in clinical treatment paradigms. Novel agents and improved regimens, coupled with more in-depth molecular and phenotypic subtyping, are driving the future of breast cancer therapy. This dynamic program will focus on the practical implications of emerging data for patient care in the clinic. Recent data and their clinical impact are highlighted throughout the program, with expert perspectives on how to apply the evidence to individualize therapy for patients with breast cancer. Current areas of controversy or uncertainty will also be debated, with discussion of ongoing clinical trials and investigational approaches designed to address these questions.
This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from and interact with international leaders in the field of breast cancer to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.
Sara A. Hurvitz, MD, FACP
Professor
Senior Vice President and Director, Clinical Research Division
Smith Family Endowed Chair in Women’s Health
Fred Hutch Cancer Center
Seattle, WA
Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology
US Oncology
Dallas, TX
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for Contact Hours.
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
There are several opportunities (both continuing education [CE] and non-CE) available for companies, associations, and societies interested in supporting this year's conference.
For Continuing Education, Associations, and Societies
Please email grants@gotoper.com for information about this upcoming conference.
Exhibitors
Exhibit at this year’s meeting and increase your visibility. Our custom sponsorship packages provide outstanding recognition and increased awareness of your company’s products and services. Don’t miss this opportunity to reach this important target audience.
For additional details, contact:
Elisha Ball | Associate Director of Sales
OncLive® Events & Intellisphere Oncology Specialty Group
Cell: (610) 563-1620
Email: egarcia@onclive.com
Maddison Martini | National Accounts Associate
OncLive® Events & Intellisphere Oncology Specialty Group
Cell: (609) 947-8377
Email: mmartini@mjhlifesciences.com
OncLive® Events & Intellisphere Oncology Specialty Group
259 Prospect Plains Rd, Building H, Monroe, NJ 08831
Web: http://www.onclive.com
Advisory Board or Ancillary Meeting Definition
Any meeting whose invited participants are professional attendees of the Conference, such as doctors and physicians will be considered an Advisory Board (Ad Board) or Ancillary Meeting. This includes activities such as round-table discussions, investigator meetings, social gatherings and meet the specialist‐type meetings.
A fee is applicable for hosting these meetings, with the amount being dependent on the type and size of your meeting.
Blackout Times
There are many programs being scheduled throughout our conferences. With that, the black out hours across our meeting are as follows:
- One day prior to the conferences
- The duration of the conference
- One day post conference
To review your meeting request, please contact Elisha Ball or Maddison Martini.
A cancellation fee of 25% will be assessed on refunds requested 90 days before the start date, a 50% fee on refunds requested 60 days before the start date, and a 75% fee on refunds requested 30 days before the start date. No refunds will be made after 30 days before the start date. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.
